Skip to main content
PMC home page
Occupational and Environmental Medicine logoLink to Occupational and Environmental Medicine
. 1998 Jan;55(1):65–70. doi: 10.1136/oem.55.1.65

Update of the morbidity experience of employees potentially exposed to chlorpyrifos

C J Burns, J B Cartmill, B S Powers, M K Lee
PMCID: PMC1757506  PMID: 9536166

Abstract

OBJECTIVES: Chlorpyrifos, an organophosphate ingredient of several important insecticides, has been manufactured at The Dow Chemical Company for 25 years. A previous morbidity study among employees of The Dow Chemical Company found no increased prevalence of illness or symptoms among employees potentially exposed to chlorpyrifos from 1977 to 1985 compared with matched controls. The purpose of the current study was to update the original study to 1994, thereby increasing the statistical power. METHODS: In the present study, 496 potentially exposed subjects were identified and matched for age, race, sex, pay, and year of hire to 911 control subjects. Morbidity data were abstracted from company medical records. RESULTS: The prevalence of peripheral neuropathy was not significantly increased among this group of employees potentially exposed to chlorpyrifos. Significantly increased prevalence odds ratios were identified for five diagnostic categories: diseases of the ear and mastoid process; acute respiratory infections; other diseases of the respiratory system; general symptoms, signs, and ill defined conditions; and symptoms, signs, and ill defined conditions involving the digestive system. There was a strong association of diagnosis with duration of observation period, indicating that the exposed workers were more likely than unexposed workers to have a diagnosis abstracted from the company medical records due to their longer mean period of follow up. Analyses by exposure classification and mean plasma cholinesterase activity did not show a dose response. CONCLUSIONS: These data do not support a cause and effect relation of the diagnoses mentioned and exposure to chlorpyrifos.

 

Full Text

The Full Text of this article is available as a PDF (109.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aiuto L. A., Pavlakis S. G., Boxer R. A. Life-threatening organophosphate-induced delayed polyneuropathy in a child after accidental chlorpyrifos ingestion. J Pediatr. 1993 Apr;122(4):658–660. doi: 10.1016/s0022-3476(05)83560-7. [DOI] [PubMed] [Google Scholar]
  2. Ames R. G., Brown S. K., Rosenberg J., Jackson R. J., Stratton J. W., Quenon S. G. Health symptoms and occupational exposure to flea control products among California pet handlers. Am Ind Hyg Assoc J. 1989 Sep;50(9):466–472. doi: 10.1080/15298668991375001. [DOI] [PubMed] [Google Scholar]
  3. Brenner F. E., Bond G. G., McLaren E. A., Green S., Cook R. R. Morbidity among employees engaged in the manufacture or formulation of chlorpyrifos. Br J Ind Med. 1989 Feb;46(2):133–137. doi: 10.1136/oem.46.2.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hodgson M. J., Block G. D., Parkinson D. K. Organophosphate poisoning in office workers. J Occup Med. 1986 Jun;28(6):434–437. doi: 10.1097/00043764-198606000-00010. [DOI] [PubMed] [Google Scholar]
  5. Kaplan J. G., Kessler J., Rosenberg N., Pack D., Schaumburg H. H. Sensory neuropathy associated with Dursban (chlorpyrifos) exposure. Neurology. 1993 Nov;43(11):2193–2196. doi: 10.1212/wnl.43.11.2193. [DOI] [PubMed] [Google Scholar]
  6. Lotti M., Moretto A., Zoppellari R., Dainese R., Rizzuto N., Barusco G. Inhibition of lymphocytic neuropathy target esterase predicts the development of organophosphate-induced delayed polyneuropathy. Arch Toxicol. 1986 Oct;59(3):176–179. doi: 10.1007/BF00316329. [DOI] [PubMed] [Google Scholar]
  7. MANTEL N., HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 Apr;22(4):719–748. [PubMed] [Google Scholar]
  8. Nolan R. J., Rick D. L., Freshour N. L., Saunders J. H. Chlorpyrifos: pharmacokinetics in human volunteers. Toxicol Appl Pharmacol. 1984 Mar 30;73(1):8–15. doi: 10.1016/0041-008x(84)90046-2. [DOI] [PubMed] [Google Scholar]
  9. Rosenstock L., Keifer M., Daniell W. E., McConnell R., Claypoole K. Chronic central nervous system effects of acute organophosphate pesticide intoxication. The Pesticide Health Effects Study Group. Lancet. 1991 Jul 27;338(8761):223–227. doi: 10.1016/0140-6736(91)90356-t. [DOI] [PubMed] [Google Scholar]
  10. Savage E. P., Keefe T. J., Mounce L. M., Heaton R. K., Lewis J. A., Burcar P. J. Chronic neurological sequelae of acute organophosphate pesticide poisoning. Arch Environ Health. 1988 Jan-Feb;43(1):38–45. doi: 10.1080/00039896.1988.9934372. [DOI] [PubMed] [Google Scholar]
  11. Soter N. A., Wasserman S. I., Austen K. F. Cold urticaria: release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge. N Engl J Med. 1976 Mar 25;294(13):687–690. doi: 10.1056/NEJM197603252941302. [DOI] [PubMed] [Google Scholar]
  12. Steenland K., Jenkins B., Ames R. G., O'Malley M., Chrislip D., Russo J. Chronic neurological sequelae to organophosphate pesticide poisoning. Am J Public Health. 1994 May;84(5):731–736. doi: 10.2105/ajph.84.5.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Yeary R. A., Eaton J., Gilmore E., North B., Singell J. A multiyear study of blood cholinesterase activity in urban pesticide applicators. J Toxicol Environ Health. 1993 May;39(1):11–25. doi: 10.1080/15287399309531733. [DOI] [PubMed] [Google Scholar]
  14. de Silva H. J., Sanmuganathan P. S., Senanayake N. Isolated bilateral recurrent laryngeal nerve paralysis: a delayed complication of organophosphorus poisoning. Hum Exp Toxicol. 1994 Mar;13(3):171–173. doi: 10.1177/096032719401300306. [DOI] [PubMed] [Google Scholar]

Articles from Occupational and Environmental Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES